TET2 and acute myeloid leukemia: Other studies10, 23, 24, 25 showed epigenetic modifier genes (EMGs) including DNMT3A, ASXL1, and TET2 were more frequent in e‐AML patients, which was thought to be associated with age‐related clonal hematopoiesis and inferior survival.